ERCC1 and cancer: These results suggest that elevated PRMT expression in cancer may serve as a mechanism to epigenetically maintain ERCC1 expression, which is critical to the survival of cancer cells that are subjected to high levels of endogenous DNA damage and increased replication-related stress.